Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Feinman

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Lipid Research|February 1, 1995
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage diseaseD Ameis, G Brockmann, R Knoblich, et al.
Hepatology (Baltimore, Md.)|April 16, 1998
Re-treatment of chronic hepatitis C with consensus interferon E J Heathcote, E B Keeffe, S S Lee, et al.
ACS ES&T Air|July 15, 2026
CIMS Detection of Hydroxymethyl Hydroperoxide: Insights into Alkene Ozonolysis in a Variety of EnvironmentsAndrew J Lindsay, Khaled Shaifullah Joy, Lee V Feinman, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic responseMaria Buti, Yoav Lurie, Natalia G Zakharova, et al.
The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.
Hepatology (Baltimore, Md.)|April 9, 2009
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patientsRobert Flisiak, Saya V Feinman, Maciej Jablkowski, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Lipid Research|February 1, 1995
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage diseaseD Ameis, G Brockmann, R Knoblich, et al.
Hepatology (Baltimore, Md.)|April 16, 1998
Re-treatment of chronic hepatitis C with consensus interferon E J Heathcote, E B Keeffe, S S Lee, et al.
ACS ES&T Air|July 15, 2026
CIMS Detection of Hydroxymethyl Hydroperoxide: Insights into Alkene Ozonolysis in a Variety of EnvironmentsAndrew J Lindsay, Khaled Shaifullah Joy, Lee V Feinman, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic responseMaria Buti, Yoav Lurie, Natalia G Zakharova, et al.
The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.
Hepatology (Baltimore, Md.)|April 9, 2009
The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patientsRobert Flisiak, Saya V Feinman, Maciej Jablkowski, et al.
Pageof 4